Clinical Trial Update: Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial compares budesonide delivered by a hydrofluoroalkane (HFA) inhaler with budesonide delivered by a chlorofluorocarbon (CFC) pressurized MDI in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide CFC pMDI (budesonide)
• Budesonide HFA (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-11-07